IPO
Aptinyx Inc.
We are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.
Symbol
APTX
Price Range
$14.00 - $16.00
Anticipated Date
TBD
Underwriters
J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets
To view the prospectus for Aptinyx Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277